全文获取类型
收费全文 | 22172篇 |
免费 | 2302篇 |
国内免费 | 647篇 |
专业分类
耳鼻咽喉 | 162篇 |
儿科学 | 592篇 |
妇产科学 | 317篇 |
基础医学 | 3263篇 |
口腔科学 | 398篇 |
临床医学 | 1581篇 |
内科学 | 4936篇 |
皮肤病学 | 394篇 |
神经病学 | 1657篇 |
特种医学 | 390篇 |
外国民族医学 | 4篇 |
外科学 | 2132篇 |
综合类 | 2589篇 |
现状与发展 | 5篇 |
一般理论 | 2篇 |
预防医学 | 1232篇 |
眼科学 | 229篇 |
药学 | 2743篇 |
2篇 | |
中国医学 | 652篇 |
肿瘤学 | 1841篇 |
出版年
2024年 | 46篇 |
2023年 | 574篇 |
2022年 | 1261篇 |
2021年 | 1143篇 |
2020年 | 951篇 |
2019年 | 1275篇 |
2018年 | 1144篇 |
2017年 | 1062篇 |
2016年 | 914篇 |
2015年 | 1003篇 |
2014年 | 1468篇 |
2013年 | 1332篇 |
2012年 | 1310篇 |
2011年 | 1493篇 |
2010年 | 1338篇 |
2009年 | 1054篇 |
2008年 | 1030篇 |
2007年 | 858篇 |
2006年 | 683篇 |
2005年 | 654篇 |
2004年 | 613篇 |
2003年 | 440篇 |
2002年 | 323篇 |
2001年 | 280篇 |
2000年 | 328篇 |
1999年 | 268篇 |
1998年 | 199篇 |
1997年 | 159篇 |
1996年 | 155篇 |
1995年 | 129篇 |
1994年 | 90篇 |
1993年 | 89篇 |
1992年 | 71篇 |
1991年 | 77篇 |
1990年 | 62篇 |
1989年 | 54篇 |
1988年 | 46篇 |
1987年 | 40篇 |
1985年 | 123篇 |
1984年 | 127篇 |
1983年 | 112篇 |
1982年 | 120篇 |
1981年 | 105篇 |
1980年 | 87篇 |
1979年 | 110篇 |
1978年 | 64篇 |
1977年 | 53篇 |
1976年 | 44篇 |
1975年 | 40篇 |
1973年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
《Pathology, research and practice》2020,216(8):153044
IntroductionmicroRNAs (miRNAs) are frequently dysregulated in many human cancers including colorectal cancer (CRC) and are useful candidate biomarkers in liquid biopsy of cancer for their stability in the blood.MethodsWe compared the expression of microRNA-9 (miR-9) in tissues (n = 357) and sera (n = 109) of CRC patients to determine whether miR-9 in serum reflects that in the cancer tissue in parallel. Also, we examined the miR-9 role in CRC by in vitro functional studies in four CRC cell lines.ResultsOn multivariate analysis of colorectal cancer tissues and sera, miR-9 low expressions were significantly associated pN stage (tissues; p < 0.01, serum; p = 0.013), and clinical stage (tissues; p < 0.01, serum; p = 0.031). Moreover, patients with low miR-9 expression had shorter survival than those with high miR-9 expression (log-rank test, tissue; p = 0.021, serum; p = 0.011). miR-9 level in serum reflects that in the tumor. The CRC cells with low miR-9 expression was significantly increased cell proliferation, migration, invasion and colony formation than cells with high miR-9 expression.ConclusionSerum miR-9 is an useful early detection marker in liquid biopsy of CRC and overexpression of miR-9 in CRC may be a novel prognostic marker as well. 相似文献
992.
目的 探讨京尼平对缺氧/复氧(H/R)损伤后大鼠心肌细胞凋亡及自噬的影响。方法 建立H/R损伤模型,体外培养的大鼠H9c2心肌细胞行缺氧12 h、复氧4 h。实验分为对照组(Con)、京尼平组(GE)、缺氧/复氧组(H/R)、缺氧/复氧+京尼平组(H/R+GE)。细胞计数试剂盒-8(CCK-8)检测细胞存活率,流式细胞仪检测细胞凋亡,透射电子显微镜观察自噬体,Western blotting检测Bax、Bcl-2、P62、Beclin1、LC3-Ⅱ、蛋白激酶B(Akt)、p-Akt、哺乳动物雷帕霉素靶蛋白(mTOR)和p-mTOR蛋白的表达。结果 京尼平预处理增强了H/R损伤后的H9c2心肌细胞活力,抑制细胞凋亡及自噬体累积,降低自噬结构断面积与细胞质断面积的比值。Western blotting结果显示,京尼平预处理减少了H/R损伤后Bax、LC3-Ⅱ和Beclin1蛋白表达,增加Bcl-2、P62、p-Akt和p-mTOR蛋白表达。结论 京尼平可以抑制H/R损伤后心肌细胞凋亡及自噬,其机制可能与上调Akt/mTOR信号通路有关。 相似文献
993.
In recent years, gene editing, especially that using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9, has made great progress in the field of gene function. Rapid development of gene editing techniques has contributed to their significance in the field of medicine. Because the CRISPR/Cas9 gene editing tool is not only powerful but also has features such as strong specificity and high efficiency, it can accurately and rapidly screen the whole genome, facilitating the administration of gene therapy for specific diseases. In the field of tumor research, CRISPR/Cas9 can be used to edit genomes to explore the mechanisms of tumor occurrence, development, and metastasis. In these years, this system has been increasingly applied in tumor treatment research. CRISPR/Cas9 can be used to treat tumors by repairing mutations or knocking out specific genes. To date, numerous preliminary studies have been conducted on tumor treatment in related fields. CRISPR/Cas9 holds great promise for gene-level tumor treatment. Personalized and targeted therapy based on CRISPR/Cas9 will possibly shape the development of tumor therapy in the future. In this study, we review the findings of CRISPR/Cas9 for tumor treatment research to provide references for related future studies on the pathogenesis and clinical treatment of tumors. 相似文献
994.
Manisha Pathak Priyanka Padghan Namrita Halder Shilpi Neeraja Kulkarni Sandip A. Sonar Girdhari Lal 《European journal of immunology》2020,50(3):404-417
The chemokine receptor CCR9 and its only known ligand CCL25 play an important role in gut inflammation and autoimmune colitis. The function of CCR9-CCL25 in the migration of immune cells is well characterized. However, its role in the immune cell differentiation is mostly not known. Using dextran sodium sulfate (DSS)-induced gut inflammation model, we showed that CCR9+ dendritic cells (DCs) specifically CD11b−CD103+ DCs were significantly increased in the gut-associated lymphoid tissues (GALT) compared to control mice. These CCR9+ DCs express lower MHC II and CD86 molecules and had regulatory surface markers (FasL and latency-associated peptide, LAP) in the GALT. In the presence of CCL25, CCR9+ DCs promoted in vitro differentiation of Foxp3+ regulatory CD4+ T cells (Tregs). CCL25-induced differentiation of Tregs was due to intrinsic signaling in the DCs but not through CD4+ T cells, which was driven by the production of thymic stromal lymphopoietin (TSLP) and not IL-10. Furthermore, adoptive transfer of CCR9+ DCs in C57BL/6 mice promoted Tregs but reduced the Th17 cells in the GALT, and also suppressed the OVA-specific gut-allergic response. Our results suggest CCR9+ DCs have a regulatory function and may provide a new cellular therapeutic strategy to control gut inflammation and allergic immune reaction. 相似文献
995.
Magali de Heusch Valérie Steenwinckel Perrine M. Cochez Jamila Louahed Guy Warnier Muriel M. Lemaire Jean-Christophe Renauld Laure Dumoutier 《European journal of immunology》2020,50(7):1034-1043
IL-9 is involved in various T cell-dependent inflammatory models including colitis, encepahlitis, and asthma. However, the regulation and specificity of IL-9 responsiveness by T cells during immune responses remains poorly understood. Here, we addressed this question using two different models: experimental colitis induced by transfer of naive CD4+CD45RBhigh T cells into immunodeficient mice, and OVA-specific T cell activation. In the colitis model, constitutive IL-9 expression exacerbated inflammation upon transfer of CD4+CD45RBhigh T cells from WT but not from Il9r−/− mice, indicating that IL-9 acts directly on T cells. Suprisingly, such naïve CD4+CD45RBhigh T cells failed to express the Il9r or respond to IL-9 in vitro, in contrast with CD4+CD45RBlow T cells. By using OVA-specific T cells, we observed that T cells acquired the capacity to respond to IL-9 along with CD44 upregulation, after long-lasting (5 to 12 days) in vivo antigenic stimulation. Il9r expression was associated with Th2 and Th17 phenotypes. Interestingly, in contrast to the IL-2 response, antigen restimulation downregulated IL-9 responsiveness. Taken together, our results demonstrate that IL-9 does not act on naïve T cells but that IL-9 responsiveness is acquired by CD4+ T cells after in vivo activation and acquisition of memory markers such as CD44. 相似文献
996.
Abdul Ahad Shuchi Smita Gyan Prakash Mishra Viplov Kumar Biswas Kaushik Sen Bhawna Gupta Dominique Garcin Hans Acha-Orbea Sunil K. Raghav 《European journal of immunology》2020,50(12):1959-1975
Plasmacytoid dendritic cells (DCs) are reported to induce robust type-I interferon (IFN) response, whereas cDC1 DCs develop moderate type-I IFN response upon TLR9 stimulation. It is very interesting to understand how this signaling under TLR9 is tightly regulated for the induction of type-I IFNs. Here, we report co-repressor protein NCoR1 as the major factor fine-tuning the signaling pathways regulating IFN-β expression under TLR9 in cDC1 DCs. We found that NCoR1 knockdown induced a robust IFN-β-mediated antiviral response upon TLR9 activation in cDC1 DCs. At the molecular level, we showed that NCoR1 directly repressed MyD88-IRF7 signaling axis in cDC1 cells. Therefore, NCoR1 depletion enhanced pIRF7 levels, IFN-β secretion, and downstream pSTAT1-pSTAT2 signaling, leading to sustained induction of IFN stimulatory genes. Integrative genomic analysis depicted strong enrichment of an antiviral gene-module in CpG-activated NCoR1 knockdown DCs upon TLR9 activation. Moreover, we confirmed our findings in primary DCs derived from splenocytes of WT and NCoR1 DC−/− animals, which showed protection from Sendai and Vesicular Stomatitis viruses upon CpG activation. Ultimately, we identified that NCoR1–HDAC3 complex is involved in repressing the type-I IFN response in cDC1 DCs. 相似文献
997.
Timothy J. Wilson Simon Clare Joseph Mikulin Christopher M. Johnson Katherine Harcourt Paul A. Lyons Gordon Dougan Kenneth G. C. Smith 《Immunology》2020,159(4):393-403
Signalling lymphocyte activation molecule family member 9 (SLAMF9) is an orphan receptor of the CD2/SLAM family of leucocyte surface proteins. Examination of SLAMF9 expression and function indicates that SLAMF9 promotes inflammation by specialized subsets of antigen-presenting cells. Within healthy liver and circulating mouse peripheral blood mononuclear cells, SLAMF9 is expressed on CD11b+, Ly6C−, CD11clow, F4/80low, MHC-II+, CX3CR1+ mononuclear phagocytes as well as plasmacytoid dendritic cells. In addition, SLAMF9 can be found on peritoneal B1 cells and small (F4/80low), but not large (F4/80high), peritoneal macrophages. Upon systemic challenge with Salmonella enterica Typhimurium, Slamf9−/− mice were impaired in their ability to clear the infection from the liver. In humans, SLAMF9 is up-regulated upon differentiation of monocytes into macrophages, and lipopolysaccharide stimulation of PMA-differentiated, SLAMF9 knockdown THP-1 cells showed an essential role of SLAMF9 in production of granulocyte–macrophage colony-stimulating factor, tumour necrosis factor-α, and interleukin-1β. Taken together, these data implicate SLAMF9 in the initiation of inflammation and clearance of bacterial infection. 相似文献
998.
Cornelius Y. Taabazuing Andrew R. Griswold Daniel A. Bachovchin 《Immunological reviews》2020,297(1):13-25
Inflammasomes are multiprotein complexes that activate inflammatory cytokines and induce pyroptosis in response to intracellular danger-associated signals. NLRP1 and CARD8 are related germline-encoded pattern recognition receptors that form inflammasomes, but their activation mechanisms and biological purposes have not yet been fully established. Both NLRP1 and CARD8 undergo post-translational autoproteolysis to generate two non-covalently associated polypeptide chains. NLRP1 and CARD8 activators induce the proteasome-mediated destruction of the N-terminal fragment, liberating the C-terminal fragment to form an inflammasome. Here, we review the danger-associated stimuli that have been reported to activate NLRP1 and/or CARD8, including anthrax lethal toxin, Toxoplasma gondii, Shigella flexneri and the small molecule DPP8/9 inhibitor Val-boroPro, focusing on recent mechanistic insights and highlighting unresolved questions. In addition, we discuss the recently identified disease-associated mutations in NLRP1 and CARD8, the potential role that DPP9’s protein structure plays in inflammasome regulation, and the emerging link between NLRP1 and metabolism. Finally, we summarize all of this latest research and consider the possible biological purposes of these enigmatic inflammasomes. 相似文献
999.
Lizhen Zhao Jie Liang Wei Rao Mengli Cui Shurong Ren Li Zhang Dan Xu Qi Han Yun-jin Zang Bei Zhang 《Scandinavian journal of immunology》2020,91(4):e12851
Acute liver injury is a common pathological basis for a variety of acute liver diseases in the clinic, which can eventually lead to liver fibrosis and even liver failure. In this study, we found that T cell Ig and mucin domain protein 3 (Tim-3) and TLR4 receptors play important roles in CCl4-induced acute liver injury. Tim-3 is a negative regulator that is expressed by T cells and macrophages. Using antibodies against Tim-3 (anti-Tim-3 Ab), we studied the Tim-3 signal in an animal model of acute liver injury and found that a large number of inflammatory factors were upregulated. In vitro experimental data shown that anti-Tim-3 Ab treatment increased interferon-ɣ production by concanavalin A (ConA)-stimulated spleen T cells, and we found that the expression level of interleukin (IL)-6 was increased in a macrophage/spleen T cell coculture system, while administration of galectin-9 (Gal-9, a Tim-3 ligand) reduced the IL-6 production. This indicates the importance of the Tim-3/Gal-9 signalling pathway in maintaining hepatic homeostasis. The Tim-3 signalling pathway inhibits TLR4-mediated NF-κB activity, and an anti-Tim-3 Ab does not affect the liver injury in TLR4-deficient mice. Regulation between Tim-3 and TLR4 determines the severity of liver damage. The negative regulation of Tim-3 reflects the protective mechanisms of patients with impaired liver function, and these results provide important information about innate and adaptive responses in the regulation of liver damage. This finding is potentially important for the study of early liver injury. 相似文献
1000.
Isabella Badolati Eva Sverremark-Ekström Marieke van der Heiden 《Scandinavian journal of immunology》2020,91(4):e12857
Since their discovery about 10 years ago, Th9 cells have been increasingly linked to allergic pathologies. Within this review, we summarize the current knowledge on associations between Th9 cells and allergic diseases and acknowledge Th9 cells as important targets in future treatment of allergic diseases. However, until today, it is not fully understood how these Th9 cell responses are modulated. We describe current literature suggesting that these Th9 cell responses might be stimulated by microbial species such as Staphylococcus aureus and Candida albicans, while on the other hand, microbial and dietary compounds such as retinoic acid (RA), butyrate and vitamin D show suppressive capacity on allergy-related Th9 responses. By reviewing this recent research, we provide new insights into the modulating capacity of the microbiota on Th9 cell responses. Consequently, microbial and dietary factors may be used as innovative tools to target Th9 cells in the treatment of allergic diseases. However, further research is needed to elucidate the mechanisms behind these interactions in order to translate this knowledge into clinical allergy settings. 相似文献